American Medical Association: Why this Black doctor volunteered for coronavirus vaccine trial
Dr. Louito Edje, UC associate dean and UC Health physician, wanted to support her patients
The American Medical Association interviewed Louito Edje, MD, associate dean of graduate medical education and designated institutional official at the University of Cincinnati College of Medicine, about the race to develop a COVID-19 vaccine and Edje’s decision to take part in a clinical trial. Too few of the people participating are Black, but it’s not surprising given the long-running difficulty that clinical trials have encountered in recruiting Black research subjects given high levels of historical mistrust.
Louito Edje, MD
Edge, a professor in the Department Medical Education and the Department of Family and Community Medicine, is also a UC Health physician. She joined the Phase 3 clinical trial for a SARS-CoV-2 vaccine. UC is one of approximately 90 sites in the U.S. to host a trial for the mRNA-1273 vaccine developed by National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
Her decision to enroll in the federally funded study was an easy one. Edje dedicates many of her working hours overseeing more than 700 resident and fellow physicians who train at UC Health. During the COVID-19 pandemic, that means ensuring learners are safe as they provide frontline care.
Read Dr. Edje’s interview with the American Medical Association online.
Related Stories
What Is Public Health Nursing? Career path and whether it’s right for you
April 6, 2026
When nurses consider graduate school, many immediately think of becoming a nurse practitioner. But there is another advanced path that is growing in demand, one focused not on treating individual patients, but on improving the health of entire communities: public health nursing.
What is the 'cicada' COVID variant?
April 6, 2026
A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.
UC opens zebrafish research facility to study infertility
April 6, 2026
The University of Cincinnati is launching a state-of-the-art zebrafish research facility that scientists say could help explain how environmental toxins affect fertility, as WKRC-TV/Local 12 and WLWT-TV/Ch. 5 recently reported.